Suppr超能文献

巨噬细胞移动抑制因子催化的酶活性中氨基末端脯氨酸作用的表征

Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.

作者信息

Stamps S L, Fitzgerald M C, Whitman C P

机构信息

Medicinal Chemistry Division, College of Pharmacy, The University of Texas, Austin 78712-1074, USA.

出版信息

Biochemistry. 1998 Jul 14;37(28):10195-202. doi: 10.1021/bi9806955.

Abstract

The cytokine macrophage migration inhibitory factor (MIF) mediates several immune and inflammatory processes through unknown or poorly understood mechanisms. The protein shares structural homology with two bacterial isomerases, 4-oxalocrotonate tautomerase (4-OT) and 5-(carboxymethyl)-2-hydroxymuconate isomerase (CHMI), and catalyzes the enolization of phenylpyruvate and the ketonization of (p-hydroxyphenyl)pyruvate. The amino-terminal proline has been identified as the catalytic base in both the 4-OT- and CHMI-catalyzed reactions. MIF also has an amino-terminal proline that has been implicated as a catalytic group in the MIF-catalyzed reaction. To delineate further the role of Pro-1 in the MIF-catalyzed reaction, affinity labeling studies were performed with 3-bromopyruvate (3-BP). The results of this study show that 3-BP acts as an active-site-directed irreversible inhibitor of the enzymatic activity and modifies one site per monomeric subunit. The inhibitor, as its lactyl derivative, is covalently attached to an 11 residue amino-terminal fragment, Pro-1 to Arg-11. The only reasonable site for alkylation within this peptide fragment is the amino-terminal proline. Because the pKa measured for the pH dependence of kinact/KI (5.7 +/- 0.2) and that measured for the pH dependence of the kcat/Km for the enolization of phenylpyruvate (6.0 +/- 0.1) are comparable and in reasonable agreement with the previously measured pKa of Pro-1 (5.6 +/- 0.1) obtained by its direct titration [Swope, M., Sun H.-W., Blake, P., and Lolis, E. (1998) EMBO J. (in press)], it is concluded that Pro-1 acts as the general base catalyst in the MIF-catalyzed reaction. The structural and mechanistic parallels place 4-OT, CHMI, and MIF in a superfamily of enzymes related by their ability to catalyze the keto-enol tautomerization of a pyruvyl moiety.

摘要

细胞因子巨噬细胞移动抑制因子(MIF)通过未知或了解甚少的机制介导多种免疫和炎症过程。该蛋白与两种细菌异构酶,即4-草酰巴豆酸互变异构酶(4-OT)和5-(羧甲基)-2-羟基粘康酸异构酶(CHMI)具有结构同源性,并催化苯丙酮酸的烯醇化和(对羟基苯基)丙酮酸的酮化。在4-OT和CHMI催化的反应中,氨基末端脯氨酸已被确定为催化碱基。MIF也有一个氨基末端脯氨酸,它被认为是MIF催化反应中的一个催化基团。为了进一步阐明Pro-1在MIF催化反应中的作用,用3-溴丙酮酸(3-BP)进行了亲和标记研究。这项研究结果表明,3-BP作为酶活性的活性位点定向不可逆抑制剂,每个单体亚基修饰一个位点。该抑制剂作为其乳酰衍生物,与一个11个残基的氨基末端片段(从Pro-1到Arg-11)共价连接。该肽片段内唯一合理的烷基化位点是氨基末端脯氨酸。因为kinact/KI的pH依赖性所测得的pKa(5.7±0.2)以及苯丙酮酸烯醇化的kcat/Km的pH依赖性所测得的pKa(6.0±0.1)与之前通过直接滴定得到的Pro-1的pKa(5.6±0.1)相当且合理一致[Swope, M., Sun H.-W., Blake, P., and Lolis, E. (1998) EMBO J. (即将发表)],所以得出结论,Pro-1在MIF催化反应中作为通用碱基催化剂。结构和机制上的相似性将4-OT、CHMI和MIF置于一个通过催化丙酮酸部分的酮-烯醇互变异构能力相关的酶超家族中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验